Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

The year 2025 marked a major leap for AI in health care, with breakthroughs in drug discovery, diagnostics, genomics and ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Abstract: The complex dynamics of the baker's map and its variants in infinite-precision mathematical domains and quantum settings have been extensively studied over the past five decades. However, ...